Trade Medivir B - MEDIVIR CFD

Trading Conditions

• Type: CFD
• Spread: 0.06
• Long position overnight funding adjustment: -0.01564%
• Short position overnight funding adjustment: -0.00658%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: SEK
• Min traded quantity: 100
• Margin: 5.00%
• Stock exchange: Sweden
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 2.42
• Open: 2.34
• 1-Year Change: 85.71%
• Day's Range: 2.28 - 2.34

Trade Medivir B - MEDIVIR CFD

What is Medivir B (MEDIVIR)?

Medivir B is a pharmaceutical company specializing in the research, development, and commercialization of innovative medicines, primarily focusing on oncology and infectious diseases. Established in Sweden, the company has a history of advancing drug candidates through various stages of clinical development, aiming to address unmet medical needs. Medivir B's portfolio includes both proprietary and partnered projects, reflecting its commitment to innovation and collaboration within the biopharmaceutical industry. The company operates with a strategic emphasis on leveraging scientific expertise and technological platforms to develop treatments that improve patient outcomes. Medivir B engages in partnerships and licensing agreements to enhance its research capabilities and expand its market reach. Its organizational structure supports a multidisciplinary approach, integrating research, clinical development, and regulatory affairs. The company is recognized for its contributions to antiviral therapies and cancer treatment research, maintaining a pipeline that includes small molecules and biologics. Medivir B's activities contribute to the broader pharmaceutical sector through its focus on novel therapeutic solutions.

Medivir B Stock Price Today: Live Overview

The price today is shaped by ongoing trading, with Medivir B standing at kr2.36. The intraday low and high range between kr2.26 and kr2.36, showing a daily variation of -6.5574%.

FAQ: Medivir B (MEDIVIR)

What is the current price of MEDIVIR stock?

Medivir B is currently priced at kr2.36.

Does MEDIVIR pay dividends?

Medivir B pays dividends to its shareholders.

Does MEDIVIR have a formal corporate presence or regional headquarters in the UAE?

Medivir B operates in the UAE through partners and distributors without an official regional office or subsidiary.

What is MEDIVIR best known for?

Medivir B is most famous for its pharmaceutical research and development in antiviral drugs.

What assets are typically shown together with MEDIVIR?

Commonly shown alongside MEDIVIR: Bright Horizons Family Solutions Inc, Stellantis NV, Grenevia SA